We are live on ! Find out more
GLSI icon

Greenwich LifeSciences

53 hedge funds and large institutions have $12.1M invested in Greenwich LifeSciences in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

0% more funds holding

Funds holding: 53 → 53 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.31% less ownership

Funds ownership: 9.23% → 8.92% (-0.31%)

18% less capital inflows, than outflows

Capital inflows: $729K | Capital outflows: $887K

Holders
53
Holders Change
–
Holders Change %
0%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
16
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GLSI Hedge Fund Activity: Q3 2025 in Review

53 of the 7,653 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2025, worth a combined $12.1M — up 8.1% from $11.2M a quarter earlier.

Fund positioning in GLSI was balanced in Q3 2025: 5 funds opened new positions, 5 closed out, 16 added to existing stakes and 14 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $243K. The largest seller was Marshall Wace, cutting an estimated $272K.

  • 53 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $12.1M of Greenwich LifeSciences stock for Q3 2025, up 8.1% quarter-over-quarter.
  • 5 funds opened new Greenwich LifeSciences positions in Q3 2025 and 5 closed out, a net change of 0 holders.
  • The largest Greenwich LifeSciences buyer in Q3 2025 was Deutsche Bank, an estimated $243K added.
  • The largest Greenwich LifeSciences seller in Q3 2025 was Marshall Wace, an estimated $272K sold.

Based on aggregated 13F filings for Q3 2025.